List view / Grid view
Yusen Logistics’ European Pharmaceutical Superhighway is contracted to carry over 1.25 million pallets this year, providing both shared and single use solutions to highly complex supply chain requirements for customers ranging from global manufacturers to small biotech companies.
9 April 2015 | By Victoria White
MedImmune has announced that it has received fast track designation from the U.S. Food and Drug Administration (FDA) for the development of MEDI8897...
9 April 2015 | By Victoria White
INO-3112 DNA immunotherapy has generated strong T cell responses in patients with head and neck cancer associated with human papillomavirus (HPV)...
9 April 2015 | By Victoria White
Exelixis has announced that the FDA has granted Fast Track designation to cabozantinib for treatment of patients with advanced renal cell carcinoma...
9 April 2015 | By Victoria White
Santhera has announced that the FDA has granted Fast Track designation for Santhera's Raxone/Catena for the treatment of Duchenne Muscular Dystrophy...
9 April 2015 | By Victoria White
Shire has announced that the Phase 2 IMAGO trial of its investigational compound SHP625 did not meet the primary or secondary endpoints...
9 April 2015 | By Victoria White
Merck has announced that grazoprevir/elbasvir has received two new Breakthrough Therapy designations from the U.S. Food and Drug Administration (FDA)...
9 April 2015 | By Victoria White
Genetic screening could improve doctors’ ability to work out which women are at increased risk of developing breast cancer, a major study has shown...
8 April 2015 | By Victoria White
Advaxis and Merck have initiated enrollment in the Phase 1/2 clinical trial evaluating the combination of ADXS-PSA and KEYTRUDA in patients with mCRPC...
8 April 2015 | By Victoria White
Lion Biotechnologies has announced that data from a study of metastatic cervical cancer patients treated with treated with HPV-TIL has been published...
8 April 2015 | By Victoria White
Capricor has announced that it has completed enrollment of the initial phase of its DYNAMIC clinical trial for the treatment of advanced heart failure...
8 April 2015 | By Victoria White
Gilead has submitted a NDA to the FDA for an investigational fixed-dose combination of F/TAF for the treatment of HIV-1 infection...
8 April 2015 | By Victoria White
The EU has approved Avastin in combination with chemotherapy for the treatment of persistent, recurrent or metastatic carcinoma of the cervix...
7 April 2015 | By Victoria White
The combined total revenues for the peer group of 35 mid-cap biotech companies increased from $24.8 billion in 2013 to $26.5 billion in 2014, representing a Compound Annual Growth Rate (CAGR) of 21.9%, according to research and consulting firm GlobalData.
7 April 2015 | By Victoria White
Ablynx has announced the start of a Phase IIb study to evaluate the efficacy and safety of ALX-0061 as a treatment for rheumatoid arthritis...
